Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors. | Heliyon | 2021 | 33688586 | PubTator, text mining | PubMed |
| Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore. | Thromb J | 2021 | 33685477 | PubTator, text mining | PubMed |
| Non-pharmaceutical Interventions and the Infodemic on Twitter: Lessons Learned from Italy during the Covid-19 Pandemic. | J Med Syst | 2021 | 33675427 | PubTator, text mining | PubMed |
| Regulation of p53 by E3s. | Cancers (Basel) | 2021 | 33670160 | PubTator, text mining | PubMed |
| Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells. | Cell Rep Med | 2021 | 33665640 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Does remote patient monitoring reduce acute care use? A systematic review. | BMJ Open | 2021 | 33653740 | PubTator, text mining | PubMed |
| TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. | Signal Transduct Target Ther | 2021 | 33640899 | PubTator, text mining | PubMed |
| Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy. | Gastric Cancer | 2021 | 33638751 | PubTator, text mining | PubMed |
| FOXP3 and Tip60 Structural Interactions Relevant to IPEX Development Lead to Potential Therapeutics to Increase FOXP3 Dependent Suppressor T Cell Functions. | Front Pediatr | 2021 | 33614551 | PubTator, text mining | PubMed |
| Cellular CARD11 Inhibits the Fusogenic Activity of Newcastle Disease Virus via CBM Signalosome-Mediated Furin Reduction in Chicken Fibroblasts. | Front Microbiol | 2021 | 33603723 | PubTator, text mining | PubMed |
| Synergy of MALT1 and mTOR inhibition in DLBCL. | Blood | 2021 | 33570607 | PubTator, text mining | PubMed |
| No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigation. | Infect Agent Cancer | 2021 | 33549143 | PubTator, text mining | PubMed |
| Canonical and Non-Canonical Roles of GRK2 in Lymphocytes. | Cells | 2021 | 33546162 | PubTator, text mining | PubMed |
| Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell Lymphoma. | JCO Precis Oncol | 2021 | 33542970 | PubTator, text mining | PubMed |
| Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract. | Sci Rep | 2021 | 33542453 | PubTator, text mining | PubMed |
| The Effect of Interleukin-4 and Dexamethasone on RNA-Seq-Based Transcriptomic Profiling of Human Podocytes: A Potential Role in Minimal Change Nephrotic Syndrome. | J Clin Med | 2021 | 33535372 | PubTator, text mining | PubMed |
| USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes. | Int J Mol Sci | 2021 | 33530560 | PubTator, text mining | PubMed |
| Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. | Arch Toxicol | 2021 | 33512557 | PubTator, text mining | PubMed |
| Annual trend of neonatal mortality and its underlying causes: population-based study - São Paulo State, Brazil, 2004-2013. | BMC Pediatr | 2021 | 33499817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=47